City Area Code
Cover [Abstract]
Current Fiscal Year End Date
Document Quarterly Report
Document Transition Report
Entity Interactive Data Current
Document Period End Date
Document Fiscal Year Focus
Document Fiscal Period Focus
Entity Common Stock, Shares Outstanding
Entity Central Index Key
Entity Emerging Growth Company
Entity Ex Transition Period
Entity Current Reporting Status
Entity Filer Category
Entity File Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Postal Zip Code
Document Information [Table]
Document Information [Line Items]
Document Type
Entity Shell Company
Series C Redeemable Preferred Stock
Series CRedeemable Preferred Stock Member
Operating lease liability, net of current portion
Operating Lease, Liability, Noncurrent
Total liabilities
Liabilities
Commitments and Contingencies
Commitments and Contingencies
Accumulated other comprehensive loss
Accumulated Other Comprehensive Income (Loss), Net of Tax
Total stockholders’ equity
Equity, Including Portion Attributable to Noncontrolling Interest
Total liabilities, convertible preferred stock, and stockholders’ equity
Liabilities and Equity
Class of Stock [Domain]
Common stock, par value (in Dollars per share)
Par value of common stock (in Dollars per share)
Common Stock, Par or Stated Value Per Share
Common stock, shares authorized (in Shares)
Common stock, shares authorized
Common Stock, Shares Authorized
Common stock, shares issued (in Shares)
Common stock, shares issued
Common Stock, Shares, Issued
Common stock, shares outstanding (in Shares)
Common stock shares outstanding
Common Stock, Shares, Outstanding
Trading Symbol
Current assets
Assets, Current [Abstract]
Cash
Cash
Accounts receivable, net
Accounts Receivable, after Allowance for Credit Loss, Current
Inventories
Total
Inventory, Net
Investor receivable
Other Receivables, Net, Current
Prepaid expenses and other current assets
Total
Prepaid Expense and Other Assets, Current
Total current assets
Assets, Current
Property and equipment, net
Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
Other income (loss)
Other Nonoperating Income (Expense)
Total other income (loss)
Nonoperating Income (Expense)
Loss before income taxes
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Net loss
Net loss
Deemed dividend Series C preferred stock
Deemed Dividend Series CPreferred Stock
Deemed dividend Series C preferred stock.
Net loss applicable to common stockholders
Net Income (Loss) Available to Common Stockholders, Basic
Change in pension benefit obligation
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent
Total comprehensive loss
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Statement of Stockholders' Equity [Abstract]
Statement [Table]
Class of Stock [Axis]
Gain on forgiveness of accounts payable
Gain Losses On Forgiveness Of Accounts Payable
Gain on forgiveness of accounts payable
Net loss per share, basic (in Dollars per share)
Earnings Per Share, Basic
Net loss per share, diluted (in Dollars per share)
Earnings Per Share, Diluted
Weighted average number of common shares outstanding, basic (in Shares)
Weighted Average Number of Shares Outstanding, Basic
Weighted average number of common shares outstanding, diluted (in Shares)
Weighted Average Number of Shares Outstanding, Diluted
Other comprehensive income (loss)
Other Comprehensive Income (Loss), Tax [Abstract]
Foreign currency translation
Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax
Series D
Series D Preferred Stock
Series D Preferred Stock [Member]
Series D Preferred Stock [Member]
Series E
Series E Preferred Stock [Member]
Series E Preferred Stock
Series E Preferred Stock [Member]
Equity Components [Axis]
Preferred Stock
Preferred Stock [Member]
Preferred Stock [Member]
Common Stock
Common Stock [Member]
Common Stock [Member]
Additional Paid-in Capital
Additional Paid-in Capital [Member]
Balance
Balance
Equity, Attributable to Parent
Balance (in Shares)
Balance (in Shares)
Shares, Outstanding
Balance (in Shares)
Treasury stock, shares of common stock (in Shares)
Balance (in Shares)
Treasury Stock, Common, Shares
Issuance of common stock in connection with the ELOC
Stock Issued During Period Value Issuance Of Common Stock In Connection With The ELOC
Issuance of common stock in connection with the ELOC.
Issuance of common stock in connection with the ELOC (in Shares)
Stock Issued Durng Period Shares Issuance Of Common Stock In Connection With The ELOC
Number of common stock issued in connection with the ELOC.
Stock-based compensation expense
APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition
Deemed dividend owed to Series C preferred stock shareholders
Deemed Dividend Owed To Series CPreferred Stock Shareholders
Deemed dividend owed to Series C preferred stock shareholders.
Organization and Basis of Presentation [Abstract]
Organization and Basis of Presentation
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Statement of Financial Position [Abstract]
Preferred stock shares outstanding (in Shares)
Redeemable preferred stock, shares outstanding
Temporary Equity, Shares Outstanding
Preferred stock, par value (in Dollars per share)
Par value of preferred stock (in Dollars per share)
Preferred Stock, Par or Stated Value Per Share
Preferred stock, shares authorized (in Shares)
Preferred stock, shares authorized
Preferred Stock, Shares Authorized
Conversion of Series E Preferred Stock to Common Stock
Conversion of Stock, Amount Converted
Conversion of Series E Preferred Stock to Common Stock (in Shares)
Convert shares
Transaction for sale of units (in Shares)
Conversion of Stock, Shares Converted
Conversion of Series D Preferred Stock to Common Stock
Stock Issued During Period Value Conversion Of Series DPreferred Stock To Common Stock
Value of conversion of series e preferred stock to common stock.
D&O insurance premium financed
Damp OInsurance Premium Financed
D&O insurance premium financed.
Conversion of Series D preferred stock to common stock
Conversion Of Series DPreferred Stock To Common Stock
Amount of conversion of Series D preferred stock to common stock.
Conversion of Series E preferred stock to common stock
Conversion Of Series EPreferred Stock To Common Stock
Amount of conversion of Series E preferred stock to common stock.
Change in fair value of subscription agreement liability - related party
Change in fair value of subscription agreement liability – related party
Change In Fair Value Of Subscription Agreement Liability Related Party
Amount of change in fair value of subscription agreement liability – related party.
Probability of Survival [Member]
Warrants purchases
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Exercise price, per share (in Dollars per share)
Class of Warrant or Right, Exercise Price of Warrants or Rights
Warrant liability (in Dollars)
Warrants and Rights Outstanding
Dividends rate
Preferred Stock, Dividend Rate, Percentage
Conversion price (in Dollars per share)
Preferred Stock, Convertible, Conversion Price
Conversion price (in Dollars per share)
Preferred Stock, Convertible, Conversion Price, Decrease
Preferred stock redeemed
Stock Redeemed or Called During Period, Shares
Aggregate amount (in Dollars)
Redemption of Series C Preferred Stock
Stock Redeemed or Called During Period, Value
Exchange of preferred stock
Exchange Of Preferred Stock
Exchange of preferred stock.
Preferred stock outstanding amount (in Dollars)
Series C Redeemable Preferred Stock, $0.00001 par value, 10,000 shares authorized, 7 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively
Temporary Equity, Carrying Amount, Attributable to Parent
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Securities Purchase Agreement [Member]
Securities Purchase Agreement Member
Series D Convertible Preferred Stock [Member]
Series DConvertible Preferred Stock Member
Class of Warrant or Right [Axis]
Class of Warrant or Right [Domain]
Series D Warrants [Member]
Series DWarrants Member
Net proceeds (in Dollars)
Proceeds from Issuance of Warrants
Proceeds from net cash (in Dollars)
Proceeds From Net Cash
Represents the amount of proceeds from net cash.
Voting rights
Preferred Stock, Voting Rights
Stock combinations of floor price (in Dollars per share)
Stock Combinations Of Floor Price
Stock combinations of floor price.
Series E Convertible Preferred Stock [Member]
Series EConvertible Preferred Stock Member
Debt Instrument [Axis]
Debt Instrument, Name [Domain]
Insurance Financing [Member]
Insurance Financing Member
Notes Payable [Line Items]
Financing fees
Payments of Financing Costs
Interest rate
Debt Instrument, Interest Rate During Period
Note payable
Notes Payable
Monthly installment payments
Debt Instrument, Periodic Payment, Principal
Warrant [Member]
Warrants [Member]
Warrant [Member]
Change in fair value
Fair Value Adjustment of Warrants
Total Liabilities
Derivative liabilities, fair value
Financial Liabilities Fair Value Disclosure
Schedule of Inventories [Abstract]
Other receivable
Other Receivables
Schedule of Goodwill [Abstract]
Balance at beginning
Goodwill
Balance at ending
Goodwill
Schedule of Company’s Derivative Liabilities and Warrant Liabilities that are Measured at Fair Value on a Recurring Basis [Line Items]
Schedule Of Change In The Fair Value Of The Derivative Liabilities And Warrant Liabilities Abstract
Warrant and Derivative Liabilities - Schedule of Change in the Fair Value of the Derivative Liabilities and Warrant Liabilities (Details) [Table]
Measurement Frequency [Axis]
Fair Value, Recurring [Member]
Fair Value, Recurring [Member]
Financial Instrument [Axis]
Derivative Liabilities [Member]
Derivative Liabilities Member
Warrant Liabilities [Member]
Warrant Liabilities Member
Schedule of Change in the Fair Value of the Derivative Liabilities and Warrant Liabilities [Line Items]
Number of Shares, Warrants vested and exercisable
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Warrants Vested And Exercisable
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are warrants vested and exercisable as of the balance sheet date.
Expected volatility [Member]
Measurement Input, Price Volatility [Member]
Expected dividend yield [Member]
Measurement Input, Expected Dividend Rate [Member]
Closing Scenario [Member]
Closing Scenario Member
Non-closing Scenario [Member]
Nonclosing Scenario Member
Schedule of Restricted Stock
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]
Schedule Of Fair Value Of Financial Instruments Measured On ARecurring Basis Abstract
Measurement Frequency [Domain]
Financial Instruments [Domain]
Proceeds from Issuance of Preferred Stock and Preference Stock
Cash Acquired from Acquisition
Series F Preferred Stock [Member]
Series D Derivative Liabilities [Member]
Gain or loss in fair value of the related party subscription liability
Gain or Loss in Fair Value of the Related Party Subscription Liability
Amount of gain or loss in fair value of the related party subscription liability.
Balance at ending
Balance at beginning
Balance at beginning
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value, Ending Balance
Conversions
Conversions of derivative liabilities
Amount of conversions of derivative liabilities.
Subscription Agreement [Member]
Subscription Agreement Member
Subscription Agreement Liability [Member]
Subscription Agreement Liability Member
Related and Nonrelated Parties [Axis]
Related and Nonrelated Parties [Domain]
Related Party [Member]
Related Party [Member]
Subscription agreement units (in Shares)
Subscription Agreement Units
Subscription Agreement, Units.
Subscription agreement liability
Subscription Agreement Liability Noncurrent
Subscription agreement liability.
Change in fair value of the related party subscription agreement liability
Change In Fair Value Of Subscription Agreement Liability
Change in fair value of subscription agreement liability.
Convertible Preferred Stock and Stockholders’ Equity [Abstract]
Convertible Preferred Stock and Stockholders’ Equity - Part 1 (Details) [Table]
Series A Convertible Preferred Stock [Member]
Series AConvertible Preferred Stock Member
Equity Component [Domain]
Veru, Inc [Member]
Veru Inc Member
Shareholder receivable (in Dollars)
Proceeds from Contributed Capital
Convertible Preferred Stock and Stockholders’ Equity - Part 3 (Details) [Table]
Summary of Significant Accounting Policies - Schedule of Fair Value of Financial Instruments Measured on a Recurring Basis (Details) [Table]
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV [Domain]
Series B Convertible Preferred Stock [Member]
Series BConvertible Preferred Stock Member
Convertible preferred stock, shares authorized
Preferred stock, shares authorized (in Shares)
Temporary Equity, Shares Authorized
Series C Convertible Preferred Stock [Member]
Series CConvertible Preferred Stock Member
Convertible preferred stock, par value (in Dollars per share)
Preferred stock, par value (in Dollars per share)
Temporary Equity, Par or Stated Value Per Share
Series D Derivative Liabilities and Warrant Liabilities [Member]
Series DDerivative Liabilities And Warrant Liabilities Member
Series E Derivative Liabilities and Warrant Liabilities [Member]
Series EDerivative Liabilities And Warrant Liabilities Member
Scenario [Axis]
Schedule Of Company SDerivative Liabilities And Warrant Liabilities That Are Measured At Fair Value On ARecurring Basis Abstract
Warrant and Derivative Liabilities - Schedule of Company’s Derivative Liabilities and Warrant Liabilities that are Measured at Fair Value on a Recurring Basis (Details) [Table]
Level 3 [Member]
Fair Value, Inputs, Level 3 [Member]
Derivative Instrument [Axis]
Plan Name [Axis]
Plan Name [Domain]
Onconetix Equity Incentive Plans [Member]
Onconetix Equity Incentive Plans Member
2022 Plan [Member]
Two Thousand Twenty Two Plan Member
PMX Option Plan [Member]
PMXOption Plan Member
Derivative Contract [Domain]
Equity Option [Member]
Equity Option [Member]
Convertible Redeemable Preferred Stock and Stockholders’ Equity [Line Items]
Convertible Redeemable Preferred Stock and Stockholders’ Equity [Line Items]
Convertible Redeemable Preferred Stock and Stockholders’ Equity [Line Items]
Contingent warrant liabilities (in Dollars)
Contingent warrant liabilities
Contingent Warrant Liabilities
Represents the amount of contingent warrant liabilities.
Reserved for issuance shares
Common Stock, Capital Shares Reserved for Future Issuance
Available shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Stock options granted (in Dollars)
Shares Granted, Value, Share-Based Payment Arrangement, Forfeited
Stock options vested (in Dollars)
Stock Issued During Period, Value, Stock Options Exercised
Expected term
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Outstanding stock options (in Dollars)
Outstanding Stock Options
Outstanding stock options.
Schedule of Activity for the Contingent Warrant Liabilities, Using Unobservable Level 3 Inputs [Line Items]
Statistical Measurement [Axis]
Minimum [Member]
Minimum [Member]
Scenario [Domain]
New Accounting Pronouncements
New Accounting Pronouncements, Policy [Policy Text Block]
Summary of Significant Accounting Policies [Abstract]
Schedule of Fair Value of Financial Instruments Measured on a Recurring Basis
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Balance Sheet Details [Abstract]
Schedule of Inventories
Schedule of Inventory, Current [Table Text Block]
Schedule of Prepaid Expenses and Other Current Assets
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]
Accrued franchise taxes
Accrual for Taxes Other than Income Taxes, Current
Total
Accrued expenses
Accrued Liabilities, Current
Schedule Of Activity For The Contingent Warrant Liabilities Using Unobservable Level3 Inputs Abstract
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Organization and Basis of Presentation (Details) [Table]
Ownership [Axis]
Ownership [Domain]
Onconetix, Inc. [Member]
Onconetix Inc Member
Proteomedix [Member]
Proteomedix Member
Organization and Basis of Presentation [Line Items]
Acquired equity interests percentage
Subsidiary, Ownership Percentage, Parent
Reverse stock split ratio description
Stockholders' Equity, Reverse Stock Split
Going Concern and Management’s Plans [Abstract]
Going Concern and Management’s Plans (Details) [Table]
Subsequent Event Type [Axis]
Significant Agreements [Abstract]
Significant Agreements (Details) [Table]
License Agreement [Member]
License Agreement Member
Related Party Transaction [Axis]
Related Party Transaction [Domain]
Series F PIPE Financing [Member]
July 2026 ELOC Purchase Agreement [Member]
July Two Thousand Twenty Six ELOC Purchase Agreement [Member]
Common stock percentage
Common Shares Percentage
The percentage of common stock.
Aggregate purchase price
Aggregate Purchase Price
The amount of aggregate purchase price.
Net cash proceeds
Proceeds from Issuance of Convertible Preferred Stock
Weighted Average Remaining Contractual Life, Outstanding Balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted-Average Remaining Contractual Term
Number of Shares, Outstanding at beginning
Number of Shares, Outstanding at ending
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance
Weighted Average Exercise Price, Outstanding at begining
Weighted Average Grant Date Fair Value, Outstanding at ending
Weighted Average Exercise Price, Outstanding at ending
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance
Restricted Stock [Member]
Restricted Stock [Member]
Dr. Meier [Member]
Dr Meier Member
Related Party Transactions [Line Items]
Percentage of success fees received
Success Fees Percentage
Success fees.
Amount of earned by the affiliated firm
Earned By The Affiliated Firm
Amount of earned by the affiliated firm.
Related expenses
Other Expenses
Accounts payable
Accounts Payable, Other
Segment Information [Abstract]
Number of business segment
Number Of Business Segment
Number of business segment.
Number of reportable segment
Number of Reportable Segments
Lease expiration date
Lease Expiration Date
Location, Statement of Income [Axis]
Location, Statement of Income [Domain]
Selling, general and administrative [Member]
Selling, General and Administrative [Member]
Research and development [Member]
Research and Development [Member]
Additional right-of-use asset
Finance Lease, Right-of-Use Asset, Amortization
Lease payment
Short-Term Lease Payments
Related Party Transactions [Abstract]
Related Party Transactions (Details) [Table]
Subsequent Event Type [Domain]
Subsequent Event [Member]
Subsequent Event [Member]
Subsequent Events [Line Items]
Commitments and Contingencies [Abstract]
Schedule Of Restricted Stock Abstract
Convertible Preferred Stock and Stockholders’ Equity - Schedule of Restricted Stock (Details) [Table]
Number of Shares, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Stockholders’ equity
Equity, Attributable to Parent [Abstract]
Common stock, $0.00001 par value, 250,000,000 shares authorized at June 30, 2026 and December 31, 2025; 3,793,676 and 31,201 shares issued at June 30, 2026 and December 31, 2025, respectively; 3,793,673 and 31,198 shares outstanding at June 30, 2026 and December 31, 2025, respectively
Common Stock, Value, Issued
Preferred Stock, value issued
Preferred Stock, Value, Issued
Additional paid-in capital
Additional Paid in Capital
Treasury stock, at cost; 3 shares of common stock at June 30, 2026 and December 31, 2025
Treasury Stock, Common, Value
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Local Phone Number
Title of 12(b) Security
Security Exchange Name
Statement [Line Items]
Total current liabilities
Liabilities, Current
Entity Registrant Name
Entity Tax Identification Number
Entity Small Business
Deferred offering costs
Deferred Costs, Noncurrent
Operating right of use asset
Operating Lease, Right-of-Use Asset
Total assets
Assets
Current liabilities
Liabilities, Current [Abstract]
Accounts payable
Accounts Payable, Current
Notes payable
Notes Payable, Current
Operating lease liability, current
Operating Lease, Liability, Current
Derivative liabilities
Derivative Liability, Current
Series A
Series A Preferred Stock [Member]
Series A Preferred Stock [Member]
Treasury Stock
Treasury Stock, Common [Member]
Accumulated Deficit
Retained Earnings [Member]
Accumulated Other Comprehensive Income
AOCI Attributable to Parent [Member]
Due from Shareholders
Due From Shareholders Member
Total Onconetix Equity (Deficit)
Parent [Member]
Net periodic pension benefit
Pension and Other Postretirement Benefits Cost (Reversal of Cost)
Accounts receivable
Increase (Decrease) in Accounts Receivable
Inventories
Increase (Decrease) in Inventories
Investor receivable
Increase (Decrease) in Other Receivables
Prepaid expenses and other current assets
Increase (Decrease) in Prepaid Expense and Other Assets
Accounts payable
Increase (Decrease) in Accounts Payable
Accrued expenses
Increase (Decrease) in Accrued Liabilities
Net cash used in operating activities
Cash used for operating activities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Cash in lieu of shares
Cash In Lieu Of Shares
Cash in lieu of shares.
Proceeds from purchases of common stock in connection with the ELOC
Proceeds from Issuance of Common Stock
Net cash provided by financing activities
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Effect of exchange rate changes on cash
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Net increase (decrease) in cash
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, beginning of period
Cash, end of period
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Other (expense) income
Nonoperating Income (Expense) [Abstract]
Interest expense
Interest Expense, Nonoperating
Warrant and Derivative Liabilities
Derivatives and Fair Value [Text Block]
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Settlement of subscription agreement liability (in Shares)
Stock Issued During Period, Share, Settlement of subscription agreement liability
Number of shares settlement of subscription agreement liability.
Settlement of subscription agreement liability
Stock Issued During Period, value, Settlement of subscription agreement liability
Amount of settlement of subscription agreement liability.
Settlement of subscription agreement liability
Amount of settlement of subscription agreement liability.
Balance Sheet Details
Supplemental Balance Sheet Disclosures [Text Block]
Preferred stock, shares issued (in Shares)
Temporary Equity, Shares Issued
Preferred stock, shares issued (in Shares)
Preferred stock, share issued
Preferred Stock, Shares Issued
Preferred stock, shares outstanding (in Shares)
Preferred shares outstanding
Preferred Stock, Shares Outstanding
Income Statement [Abstract]
Revenue
Revenues
Cost of revenue
Cost of Revenue
Gross profit
Gross Profit
Cancellation of restricted common stock
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures
Cancellation of restricted common stock (in Shares)
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures
Cash in lieu of shares
Stock Issued During Period, Value, Other
Cash in lieu of shares (in Shares)
Stock Issued During Period, Shares, Other
Foreign currency translation adjustment
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]
Loss on impairment of goodwill
Impairment of goodwill
Goodwill impairment losses
Goodwill, Impairment Loss
Amortization of debt discounts
Amortization of Debt Discount (Premium)
Depreciation and amortization
Depreciation, Depletion and Amortization, Nonproduction
Change in fair value of contingent warrant liabilities
Change In Fair Value Of Contingent Warrant Liabilities
Amount of expense (income) related to adjustment to fair value of contingent warrant liabilities.
Change in fair value of Series D Derivative Liability
Change In Fair Value Of Derivative Liabilities
Amount of expense (income) related to adjustment to fair value of derivative liabilities.
Change in fair value of Series E Derivative Liability
Change in fair value of Series E derivative liability
Change In Fair Value Of Series EDerivative Liability
Amount of change in fair value of series E derivative liability.
Conversion of Series D Preferred Stock to Common Stock (in Shares)
Stock Issued During Period Shares Conversion Of Series DPreferred Stock To Common Stock
Number of shares on conversion of Series D Preferred Stock to Common Stock.
Issuance of Common Stock for Warrant Exercise
Conversion of Stock, Amount Issued
Issuance of Common Stock for Warrant Exercise (in Shares)
Conversion of Stock, Shares Issued
Changes in pension benefit obligation
Stock Issued During Period, Value, Employee Benefit Plan
Statement of Cash Flows [Abstract]
Cash flows from operating activities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Stock-based compensation
Share-Based Payment Arrangement, Noncash Expense
Gain on forgiveness of accounts payable
Gain On Forgiveness Of Accounts Payable
Amount of gain on forgiveness of accounts payable.
Change in fair value of contingent warrant liabilities
Liabilities, Fair Value Adjustment
Change in fair value of Series D derivative liability
Change In Fair Value Of Series DDerivative Liability
Amount of change in fair value of Series D derivative liability.
Disposal of property and equipment
Gain (Loss) on Disposition of Property Plant Equipment
Changes in operating assets and liabilities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Cash flows from investing activities
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
Net cash Provided by (used in) investing activities
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Cash flows from financing activities
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Proceeds from issuance of note payable
Proceeds from Notes Payable
Principal payments of notes payable
Repayments of Notes Payable
Payment for redemption of Series C Preferred Stock
Payments for Repurchase of Preferred Stock and Preference Stock
Proceeds from exercise of warrants
Proceeds from Warrant Exercises
Going Concern and Management’s Plans
Substantial Doubt about Going Concern [Text Block]
Notes Payable
Debt Disclosure [Text Block]
Subscription Agreement [Abstract]
Subscription Agreement
Subscription Agreement Disclosure Text Block
The entire disclosure for subscription agreement.
Warrant and Derivative Liabilities [Abstract]
Segment Information
Segment Reporting [Text Block]
Subsequent Events [Abstract]
Subsequent Events
Subsequent Events [Text Block]
Significant Agreements
Significant Agreements Text Block
The entire disclosure for significant agreements.
Notes Payable [Abstract]
Convertible Preferred Stock and Stockholders’ Equity
Equity [Text Block]
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Related Party Transactions
Related Party Transactions Disclosure [Text Block]
Net Loss Per Share [Abstract]
Net Loss Per Share
Earnings Per Share [Text Block]
Operating expenses
Operating Expenses [Abstract]
Selling, general, and administrative
Selling, General and Administrative Expense
Research and development
Research And Development Expenses
Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
Total operating expenses
Operating Expenses
Loss from operations
Operating Income (Loss)
Supplemental disclosure of cash flow information:
Supplemental Cash Flow Information [Abstract]
Cash paid for interest
Interest Paid, Excluding Capitalized Interest, Operating Activity
Noncash investing and financing activities:
Noncash Investing and Financing Items [Abstract]
Schedule Of Inputs Used To Determine The Fair Value Of The Derivative And Warrant Liabilities Abstract
Fair Value Measurement Inputs and Valuation Techniques [Table]
Risk-free interest rate [Member]
Measurement Input, Risk Free Interest Rate [Member]
Probability [Member]
Probability Member
Maximum [Member]
Maximum [Member]
Measurement Input Type [Axis]
Expected term (years) [Member]
Measurement Input, Expected Term [Member]
Raw materials
Inventory, Raw Materials, Gross
Finished goods
Inventory, Finished Goods, Gross
Schedule of Prepaid Expenses and Other Current Assets [Abstract]
Prepaid insurance
Prepaid Insurance
VAT taxes receivable
Value Added Tax Receivable, Current
Prepaid other
Other Prepaid Expense, Current
Impairment loss
Goodwill, Impairment Loss, Net of Tax
Foreign currency translation
Goodwill, Foreign Currency Translation, Gain (Loss)
Schedule of Accrued Expenses [Abstract]
Accrued compensation
Accrued Employee Benefits, Current
Accrued professional fees
Accrued Professional Fees, Current
Other accrued expenses
Other Accrued Liabilities, Current
Change in fair value
Change In Fair Value Adjustments Of Warrants Liability
Amount of expense (income) related to adjustment to fair value of warrant liability.
Schedule Of Outstanding Warrants Abstract
Weighted Average Exercise Price, Warrants vested and exercisable
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
Weighted average exercise price of warrants vested and exercisable.
Weighted Average Remaining Contractual Life, Warrants vested and exercisable
Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
Weighted average remaining contractual life of warrants vested and exercisable.
Number of Shares, Exercised
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised
The number of equity-based payment instruments, excluding stock (or unit) options, that exercised during the reporting period.
Weighted Average Exercise Price, Exercised
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period
The weighted average exercise price of warrants exercised.
Repurchase shares of common stock
Share Repurchase Program, Authorized, Number of Shares
Price per share (in Dollars per share)
Shares Acquired, Average Cost Per Share
Repurchases stock (in Dollars)
Stock Repurchased During Period, Value
Schedule of Stock-Based Compensation Expense
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Schedule of Computation of Diluted Shares Outstanding
Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]
Schedule of Revenue by Geographical Area
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Customer, Extent of Reliance [Table Text Block]
Contingent warrant liabilities [Member]
Contingent Warrant Liability [Member]
Contingent Warrant Liability Member
Series D and E derivative liabilities [Member]
Series DAnd EDerivative Liabilities Member
Schedule of Fair Value of Financial Instruments Measured on a Recurring Basis [Line Items]
Liabilities:
Liabilities, Fair Value Disclosure [Abstract]
Series C Warrants [Member]
Series CPIPEWarrants Member
Balance Sheet Details (Details) [Table]
Balance Sheet Details [Line Items]
Number of designated shares
Number Of Designated Shares
Number of designated shares.
Conversion of preferred stock
Preferred Stock, Convertible, Shares Issuable
Convertible stock outstanding
Stock Issued During Period, Shares, Conversion of Convertible Securities
Convertible Preferred Stock and Stockholders’ Equity - Part 2 (Details) [Table]
ELOC [Member]
ELOCMember
Series E Preferred Stock PIPE Securities [Member]
Series EPreferred Stock PIPESecurities Member
Maximum sale of common stock (in Dollars)
Maximum Sale Of Newly Issued Common Stock
The maximum amount of newly issued common stock for sale.
Shares of common stock value (in Dollars)
Shares Of Common Stock Value
Shares of common stock value.
Level 1 [Member]
Fair Value, Inputs, Level 1 [Member]
Level 2 [Member]
Fair Value, Inputs, Level 2 [Member]
Schedule of Change in the Fair Value of the Derivative Liabilities and Warrant Liabilities
Schedule Of Change In The Fair Value Of The Derivative Liabilities And Warrant Liabilities Table Text Block
Tabular disclosure of change in the fair value of the derivative liabilities and warrant liabilities.
Schedule of Outstanding Warrants
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
Going Concern and Management’s Plans [Line Items]
Working capital deficit
Working Capital Deficit
Working capital deficit.
Schedule of Inputs Used to Determine the Fair Value of the Derivative and Warrant Liabilities [Line Items]
Derivative liabilities, measurement inputs
Derivative Liability, Measurement Input
Immunovia AB [Member]
Immunovia ABMember
Significant Agreements [Line Items]
Non-refundable upfront license fee
Non Refundable Upfront License Fee
The amount of non-refundable upfront license fee.
License revenue
Contract with Customer, Liability, Revenue Recognized
Payments for study-related services
Professional and Contracted Services Expense
Notes Payable (Details) [Table]
Due date
Debt Instrument, Maturity Date
Subscription Agreement (Details) [Table]
Sale of Stock [Axis]
Sale of Stock [Domain]
Subscription Agreement [Line Items]
Sale of units (in Shares)
Units Issued During Period Shares New Issues
Number of new units issued during the period.
Pre fund warrant (in Dollars per share)
Units Issued During Period Warrants Pre Funded
Number of new warrant issued during the period.
Price per unit (in Dollars per share)
Shares Issued, Price Per Share
Provision for interest
Provision For Interest Debenture
Provision for contract interest debenture.
Interest rate percentage
Interest Rate Percentage
Interest rate percentage.
Series Seed Preferred Stock [Member]
Series Seed Preferred Stock Member
Series B Preferred Stock [Member]
Series B Preferred Stock [Member]
Series C Preferred Stock [Member]
Series C Preferred Stock [Member]
Statistical Measurement [Domain]
Measurement Input Type [Domain]
ELOC Purchase Agreement [Member]
ELOCPurchase Agreement Member
Percentage of common stock outstanding
Percentage Of Common Stock Outstanding
Percentage of Common Stock Outstanding.
Gross proceeds sale of common stock
Gross Proceeds From Sale Of Common Stock
The percentage value of gross proceeds sale of common stock.
Trading days
Trading Days
The number of trading days.
Series D and E Warrants [Member]
Fair Value Measurements
Fair Value Measurement, Policy [Policy Text Block]
Schedule of Goodwill
Goodwill [Table Text Block]
Schedule of Accrued Expenses
Schedule of Accrued Liabilities [Table Text Block]
Schedule of Activity for the Contingent Warrant Liabilities, Using Unobservable Level 3 Inputs
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Schedule of Inputs Used to Determine the Fair Value of the Derivative and Warrant Liabilities
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
Schedule of Company’s Derivative Liabilities and Warrant Liabilities that are Measured at Fair Value on a Recurring Basis
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]
Other notes payable (in Dollars)
Other Notes Payable
Schedule of Restricted Stock [Line Items]
Schedule of Stock-Based Compensation Expense [Line Items]
Schedule of Stock Options [Line Items]
Number of Shares, Forfeited
Number of Shares, Cancelled
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Weighted Average Grant Date Fair Value, Forfeited
Weighted Average Exercise Price, Cancelled
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Schedule of Computation of Diluted Shares Outstanding [Abstract]
Options to purchase shares of common stock
Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements
Warrants
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
Unvested shares of restricted stock
Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends
Common stock issuable upon conversion of Series C Redeemable Preferred Stock
Incremental Common Stock Issuable Upon Conversion Of Series CRedeemable Preferred Stock
Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.
Class of Warrant or Right [Table]
Weighted Average Exercise Price, Granted
Weighted Average Grant Date Fair Value, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Geographical [Axis]
Geographical [Domain]
United States [Member]
UNITED STATES
United Kingdom [Member]
UNITED KINGDOM
Switzerland [Member]
SWITZERLAND
Schedule of Revenue by Geographical Area [Line Items]
Schedule of Outstanding Warrants [Line Items]
Segment Reporting [Table]
Commitment fee
Other Commitment, Total
Number of Shares, Vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Weighted Average Grant Date Fair Value, Vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Schedule Of Stock Based Compensation Expense Abstract
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Total stock-based compensation expense
Share-Based Payment Arrangement, Expense
Approach of CODM to determine segment information
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Subsequent Events (Details) [Table]
Conversions of preferred stock
Convertible Preferred Stock, Shares Issued upon Conversion
Additionally received amount (in Dollars)
Sale of Stock, Consideration Received on Transaction
Common stock issuable upon conversion of Series D Redeemable Preferred Stock
Incremental Common Shares Attributable To Conversion Of Series DPreferred Stock
Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.
Common stock issuable upon conversion of Series E Redeemable Preferred Stock
Incremental Common Stock Issuable Upon Conversion Of Series ERedeemable Preferred Stock
Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.
Total
Weighted Average Number of Shares Outstanding, Diluted, Adjustment
Schedule Of Revenue By Geographical Area Abstract
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Customer, Extent of Reliance [Table]
Amendment Flag
Chief Financial Officer